Detalhe da pesquisa
1.
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
N Engl J Med
; 381(18): 1718-1727, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31566307
2.
Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study.
Ann Rheum Dis
; 78(6): 754-760, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30902820
3.
Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 655064, an Antagonistic Anti-CD40 Antibody, in Healthy Subjects: A Potential Novel Treatment for Autoimmune Diseases.
J Clin Pharmacol
; 58(12): 1566-1577, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30113724
4.
Bacterial consumption of humic and non-humic low and high molecular weight DOM and the effect of solar irradiation on the turnover of labile DOM in the Southern Ocean.
Microb Ecol
; 50(1): 90-101, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16052379